Literature DB >> 31919880

Haptoglobin genotype predicts severe acute vaso-occlusive pain episodes in children with sickle cell anemia.

Shaina M Willen1, Joel Brennan McNeil2, Mark Rodeghier3, Vern Eric Kerchberger2, Ciara M Shaver2, Julie A Bastarache2,4,5, Martin H Steinberg6, Michael R DeBaun7, Lorraine B Ware2,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31919880      PMCID： PMC7343605          DOI： 10.1002/ajh.25728

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   13.265


× No keyword cloud information.
  31 in total

1.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

Authors:  Andrew P Levy; Irit Hochberg; Kathleen Jablonski; Helaine E Resnick; Elisa T Lee; Lyle Best; Barbara V Howard
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

2.  Erythroid DAMPs drive inflammation in SCD.

Authors:  Mark T Gladwin; Solomon F Ofori-Acquah
Journal:  Blood       Date:  2014-06-12       Impact factor: 22.113

3.  Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.

Authors:  Kim R Quimby; Ian R Hambleton; R Clive Landis
Journal:  Med Hypotheses       Date:  2015-06-29       Impact factor: 1.538

4.  The cooperative study of sickle cell disease: review of study design and objectives.

Authors:  M Gaston; W F Rosse
Journal:  Am J Pediatr Hematol Oncol       Date:  1982

Review 5.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

Authors:  E P Vichinsky; L A Styles; L H Colangelo; E C Wright; O Castro; B Nickerson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

7.  Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis.

Authors:  Kymberley Carter; Derrick J Bowen; C Anne McCune; Mark Worwood
Journal:  Br J Haematol       Date:  2003-07       Impact factor: 6.998

Review 8.  Biological and clinical significance of haptoglobin polymorphism in humans.

Authors:  M R Langlois; J R Delanghe
Journal:  Clin Chem       Date:  1996-10       Impact factor: 8.327

9.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

10.  Comorbidity, Pain, Utilization, and Psychosocial Outcomes in Older versus Younger Sickle Cell Adults: The PiSCES Project.

Authors:  Donna K McClish; Wally R Smith; James L Levenson; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Viktor E Bovbjerg
Journal:  Biomed Res Int       Date:  2017-03-28       Impact factor: 3.411
View more
  2 in total

1.  Toxic effects of cell-free hemoglobin on the microvascular endothelium: implications for pulmonary and nonpulmonary organ dysfunction.

Authors:  Jamie E Meegan; Julie A Bastarache; Lorraine B Ware
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

Review 2.  Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients.

Authors:  Olivia Edwards; Alicia Burris; Josh Lua; Diana J Wilkie; Miriam O Ezenwa; Sylvain Doré
Journal:  Genes (Basel)       Date:  2022-01-14       Impact factor: 4.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.